Endothelin B receptor expression correlates with tumour angiogenesis and prognosis in oesophageal squamous cell carcinoma

British Journal of Cancer

Volumn 110, Issue 4, 2014, Pages 1027-1033

  Tanaka, T ^a   Sho, M ^a   Takayama, T ^a   Wakatsuki, K ^a   Matsumoto, S ^a   Migita, K ^a   Ito, M ^a   Hamada, K ^a   Nakajima, Y ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIGENS, CD45; CARCINOMA, SQUAMOUS CELL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTOR, ENDOTHELIN B; SURVIVAL; TUMOR MARKERS, BIOLOGICAL;

EID: 84894346465     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.784     Document Type: Article

References (37)

1. Bagnato A, Loizidou M, Pflug BR, Curwen J, Growcott J (2011) Role of the endothelin axis and its antagonists in the treatment of cancer. Br J Pharmacol 163(2): 220-233.
2. Bagnato A, Spinella F, Rosano L (2008) The endothelin axis in cancer: The promise and the challenges of molecularly targeted therapy. Can J Physiol Pharmacol 86(8): 473-484.
3. Buckanovich RJ, Facciabene A, Kim S, Benencia F, Sasaroli D, Balint K, Katsaros D, O'Brien-Jenkins A, Gimotty PA, Coukos G (2008) Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat Med 14(1): 28-36.
4. Carducci MA, Padley RJ, Breul J, Vogelzang NJ, Zonnenberg BA, Daliani DD, Schulman CC, Nabulsi AA, Humerickhouse RA, Weinberg MA, Schmitt JL, Nelson JB (2003) Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: A randomized, phase II, placebo-controlled trial. J Clin Oncol 21(4): 679-689.
5. Courrech Staal EF, van Coevorden F, Cats A, Aleman BM, van Velthuysen ML, Boot H, Peeters MJ, van Sandick JW (2009) Outcome of low-volume surgery for esophageal cancer in a high-volume referral center. Ann Surg Oncol 16(12): 3219-3226.
6. Eltze E, Bertolin M, Korsching E, Wulfing P, Maggino T, Lelle R (2007) Expression and prognostic relevance of endothelin-B receptor in vulvar cancer. Oncol Rep 18(2): 305-311.
7. Enomoto K, Sho M, Wakatsuki K, Takayama T, Matsumoto S, Nakamura S, Akahori T, Tanaka T, Migita K, Ito M, Nakajima Y (2012) Prognostic importance of tumour-infiltrating memory T cells in oesophageal squamous cell carcinoma. Clin Exp Immunol 168(2): 186-191.
8. Feldstein C, Romero C (2007) Role of endothelins in hypertension. Am J Ther 14(2): 147-153.
9. Grimshaw MJ, Hagemann T, Ayhan A, Gillett CE, Binder C, Balkwill FR (2004) A role for endothelin-2 and its receptors in breast tumor cell invasion. Cancer Res 64(7): 2461-2468.
10. Guruli G, Pflug BR, Pecher S, Makarenkova V, Shurin MR, Nelson JB (2004) Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops. Blood 104(7): 2107-2115.
11. Herrmann E, Bogemann M, Bierer S, Eltze E, Hertle L, Wulfing C (2006) The endothelin axis in urologic tumors: Mechanisms of tumor biology and therapeutic implications. Expert Rev Anticancer Ther 6(1): 73-81.
12. Igarashi M, Dhar DK, Kubota H, Yamamoto A, El-Assal O, Nagasue N (1998) The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer 82(7): 1225-1232.
13. Iglarz M, Clozel M (2007) Mechanisms of ET-1-induced endothelial dysfunction. J Cardiovasc Pharmacol 50(6): 621-628.
14. Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Sho M, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M (1999) Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 79(9-10): 1553-1563.
15. Ishibashi Y, Hanyu N, Nakada K, Suzuki Y, Yamamoto T, Takahashi T, Kawasaki N, Kawakami M, Matsushima M, Urashima M (2003) Endothelin protein expression as a significant prognostic factor in oesophageal squamous cell carcinoma. Eur J Cancer 39(10): 1409-1415.
16. Jiao W, Xu J, Zheng J, Shen Y, Lin L, Li J (2008) Elevation of circulating big endothelin-1: An independent prognostic factor for tumor recurrence and survival in patients with esophageal squamous cell carcinoma. BMC Cancer 8: 334.
17. Jiao WJ, Xu J, Pan H, Wang TY, Shen Y (2007) Effect of endothelin-1 in esophageal squamous cell carcinoma invasion and its correlation with cathepsin B. World J Gastroenterol 13(29): 4002-4005.
18. Kandalaft LE, Facciabene A, Buckanovich RJ, Coukos G (2009) Endothelin B receptor, a new target in cancer immune therapy. Clin Cancer Res 15(14): 4521-4528.
19. Kitadai Y, Haruma K, Tokutomi T, Tanaka S, Sumii K, Carvalho M, Kuwabara M, Yoshida K, Hirai T, Kajiyama G, Tahara E (1998) Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin Cancer Res 4(9): 2195-2200.
20. Lehrke I, Waldherr R, Ritz E, Wagner J (2001) Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria. J Am Soc Nephrol 12(11): 2321-2329.
21. Levin ER (1995) Endothelins. N Engl J Med 333(6): 356-363.
22. Matsumoto S, Yamada Y, Narikiyo M, Ueno M, Tamaki H, Miki K, Wakatsuki K, Enomoto K, Yokotani T, Nakajima Y (2007) Prognostic significance of platelet-derived growth factor-BB expression in human esophageal squamous cell carcinomas. Anticancer Res 27(4B): 2409-2414.
23. Nelson J, Bagnato A, Battistini B, Nisen P (2003) The endothelin axis: Emerging role in cancer. Nat Rev Cancer 3(2): 110-116.
24. Nelson JB (2003) Endothelin inhibition: Novel therapy for prostate cancer. J Urol 170(6 Pt 2): S65-S67 (discussion S67-68).
25. Okines A, Sharma B, Cunningham D (2010) Perioperative management of esophageal cancer. Nat Rev Clin Oncol 7(4): 231-238.
26. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2): 74-108.
27. Salani D, Taraboletti G, Rosano L, Di Castro V, Borsotti P, Giavazzi R, Bagnato A (2000) Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 157(5): 1703-1711.
28. Shen C, Yang L, Yuan X (2011) Endothelin B receptor expression in human astrocytoma: Association with clinicopathological variables and survival outcomes. Int J Neurosci 121(11): 626-631.
29. Spinella F, Garrafa E, Di Castro V, Rosano L, Nicotra MR, Caruso A, Natali PG, Bagnato A (2009) Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade. Cancer Res 69(6): 2669-2676.
30. Spinella F, Rosano L, Di Castro V, Natali PG, Bagnato A (2002) Endothelin-1 induces vascular endothelial growth factor by increasing hypoxiainducible factor-1alpha in ovarian carcinoma cells. J Biol Chem 277(31): 27850-27855.
31. Tanigawa N, Matsumura M, Amaya H, Kitaoka A, Shimomatsuya T, Lu C, Muraoka R, Tanaka T (1997) Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer 79(2): 220-225.
32. Tomobe Y, Miyauchi T, Saito A, Yanagisawa M, Kimura S, Goto K, Masaki T (1988) Effects of endothelin on the renal artery from spontaneously hypertensive and Wistar Kyoto rats. Eur J Pharmacol 152(3): 373-374.
33. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324(1): 1-8.
34. Wulfing P, Kersting C, Tio J, Fischer RJ, Wulfing C, Poremba C, Diallo R, Bocker W, Kiesel L (2004) Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer. Clin Cancer Res 10(7): 2393-2400.
35. Wuttig D, Zastrow S, Fussel S, Toma MI, Meinhardt M, Kalman K, Junker K, Sanjmyatav J, Boll K, Hackermuller J, Rolle A, Grimm MO, Wirth MP (2012) CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases. Int J Cancer 131(5): E693-E704.
36. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332(6163): 411-415.
37. Zhao BJ, Sun DG, Zhang M, Tan SN, Ma X (2009) Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma. Dis Esophagus 22(1): 55-61.